Rigel Pharmaceuticals Inc (RIGL)
SG&A Expense Growth
6.50%
Quarterly · Period ending:
RIGL SG&A Expense Growth
Latest reported6.50%period ending
Latest reported6.50%period ending
RIGL Quarterly SG&A Growth (QoQ) (0.00% → 6.50%)
Latest values, visible window
High-resolution chart · PNG
RIGL sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -1.4278% | |
| -70.6832% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |